# HMB Enriched Amino Acids to Reverse Muscle Loss in Cirrhosis

> **NCT05166499** · NA · RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 24 (estimated)

## Conditions studied

- Cirrhosis, Liver

## Interventions

- **DIETARY_SUPPLEMENT:** Hydroxy Methyl Butyrate
- **DIETARY_SUPPLEMENT:** Balanced Amino Acids

## Key facts

- **NCT ID:** NCT05166499
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05166499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05166499, "HMB Enriched Amino Acids to Reverse Muscle Loss in Cirrhosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05166499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*